Research and Development

UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …

Pfizer’s rheumatoid arthritis treatment tofacitinib has induced clinical remission of the disease according to one-year data from a phase III …

Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial. Five years’ worth of mid-stage data …

GlaxoSmithKline is to sell off its weight loss drug Alli and other less profitable non-prescription drugs. GSK announced its decision …

Revenues at Roche flattened out in the first three months of 2011, as Avastin sales declined in the US and Europe. Group …

Watermeadow Medical is delighted to welcome seven new staff to its UK offices. The appointments have been made as demand …

Swiss contract manufacturer and fine chemicals company Lonza has said it plans to expand its biopharmaceutical production unit in Slough, …

The FDA advisory committee has unanimously backed Novartis’ Afinitor for neuroendocrine tumours of pancreatic origin.  The recommendation comes from the …

 Wainwright Associates are offering you the opportunity to attend a FREE thirty minute webinar on “The roles and responsibilities of …

Head of oncology at Merck Serono Wolfgang Wein explains how his field is changing, the best thing about his role …

In the US the False Claims Act regulates those who attempt to defraud the government. In the last 20 years, …

Merck & Co is to buy ophthalmic specialist Inspire Pharmaceuticals in a $430 million deal which sees it move further …

Boehringer Ingelheim has identified Pradaxa as one of the cornerstones of its “new growth phase” as the manufacturer seeks to …

Pfizer Belgium has promoted Kris Westelinck to the role of president. Kris was previously managing director and head of Pfizer’s …

The ABPI has appointed former Prudential communications director Stephen Whitehead as its new head. He joins the UK pharma industry …